Calycosin Inhibits Intestinal Fibrosis on CCD-18Co Cells via Modulating Transforming Growth Factor-β/Smad Signaling Pathway
Sign Up to like & getrecommendations! Published in 2019 at "Pharmacology"
DOI: 10.1159/000500186
Abstract: Background: Intestinal fibrosis is the major complication of Crohn’s disease (CD). There are no other good treatments for CD except surgery and remains a refractory disease. Calycosin (CA), the active component of astragalus membranaceus, has… read more here.
Keywords: intestinal fibrosis; fibrosis; ccd 18co; 18co cells ... See more keywords